Invited presentation made at the 13th International Conference on Nanomedicine and Pharmaceutical Nanotechnology at Aurelio, Rome, Italy, during July 24-25, 2017.
In June this year, Prof Martin-Sanchez traveled to Heidelberg, Germany to represent HBIR and University of Melbourne participating in a three day scientific symposium "Biomedical Informatics: Confluence of Multiple Disciplines”.
These are the slides from the presentation he gave to the symposium.
Path-breaking directions of nanotechnology-based chemotherapy and molecular c...UNU-MERIT
This working paper analyzes the path-breaking directions of nanotechnology-based chemotherapy and molecular cancer therapy. It finds two main waves of cancer treatment using nanotechnology: 1) In the early 2000s, nanotechnology was applied to broad-spectrum chemotherapy agents. 2) After 2006, a second wave appeared using nanotechnology in chemotherapy agents and molecular targeted therapies for cancers like breast, lung, brain and colon. The paper also finds that since the late 2000s, research has intensified on treatments for cancers with high mortality rates like pancreatic and brain cancer. It shows countries specializing in specific cancers, such as Switzerland in prostate cancer and Japan in colon cancer. The ground-breaking trajectories of nanotechnology are generating revolutionary new treatments that
application of nanoparticles in the early diagnosis and treatment of tumors: ...LucyPi1
Abstract
Objective: Malignant tumors pose a serious threat to human life and health. Despite recent developments in
modern medical techniques, the early diagnosis and treatment of tumors remain difficult due to their asymptomatic
nature in the early stages of disease and the limitations in current clinical diagnostic methods. Advancements in
nanotechnology, particularly in the area of multi-functional diagnostic nanomaterials, can help effectively resolve
present inadequacies via concurrently achieving early diagnosis, image-guided intervention, and real-time
monitoring and treatment of tumors. The development of nanomaterials and nanotechnology may also aid in the
area of anti-cancer drug development by improving the safety and side-effect profile, as well as by enhancing the
targeted specificity of the drugs, which are two of the long-standing challenges in Western medicine. The progress
in the field of nanomaterials has also uncovered novel approaches for the clinical application of traditional Chinese
medicine because the combination of traditional Chinese medicine components with nanoparticles overcomes
various drawbacks, including poor water solubility, low bioavailability, and short half-life, of the former. Moreover,
nanoparticles also enhance the biological effectiveness and targeted specificity of these medicines. In this review,
we discuss the application of nanoparticles in the early diagnosis and treatment of tumors, through modern and
traditional medicine.
Scientific Research And Ethics by Manu ShreshthaManu Shreshtha
This document presents an overview of ethics with respect to science and research. It begins with definitions of ethics and discusses ethical theories like deontology, teleology, and utilitarianism. It then examines important historical events that shaped modern research ethics like the Nazi medical experiments and the Nuremberg Code. The document outlines principles for ethical research like informed consent and protecting vulnerable subjects. It discusses ethical concerns in qualitative and quantitative research and emphasizes the importance of ethics in protecting participants and ensuring research is conducted safely and for the benefit of all.
Novel biotechnologies : intervening in the brain Ilya Klabukov
This document from the Nuffield Council on Bioethics examines the ethical issues related to novel neurotechnologies that can intervene in the human brain. It discusses technologies like deep brain stimulation, transcranial magnetic stimulation, brain-computer interfaces, and neural stem cell therapies. The report analyzes the ethical considerations regarding how these technologies are developed, tested, regulated, and applied both for medical purposes and non-medical uses.
Thank You for referencing this work, if you find it useful!
Citation of a related scientific book:
Wac, K., Wulfovich, S. (2021). Quantifying Quality of Life, Series: Health Informatics, Springer Nature, Cham, Switzerland. The talk details:
Katarzyna Wac, “Remote quality of life assessment: ‘What is always speaking silently is the body'”. Digital Health Connect Conference, Sion, Switzerland
Video: https://www.digitalhealthconnect.ch/en/
introduction Bio ethics and preclinical and clinical trial by srota dawnSrota Dawn
Bioethics involves studying the ethical implications of biological discoveries and medical advances. It examines what decisions are morally right regarding issues in fields like genetics and drug research. Regulations like the Hippocratic Oath and more modern frameworks provide guidance. Preclinical research ethics evaluates a potential drug's effects through non-human animal tests before human trials. These aim to reduce animal use, refine methods, and replace animals when possible. Clinical trials in humans have phases to assess safety, efficacy, and long-term effects compared to existing treatments. Regulations like CPCSEA in India oversee animal welfare in research.
In June this year, Prof Martin-Sanchez traveled to Heidelberg, Germany to represent HBIR and University of Melbourne participating in a three day scientific symposium "Biomedical Informatics: Confluence of Multiple Disciplines”.
These are the slides from the presentation he gave to the symposium.
Path-breaking directions of nanotechnology-based chemotherapy and molecular c...UNU-MERIT
This working paper analyzes the path-breaking directions of nanotechnology-based chemotherapy and molecular cancer therapy. It finds two main waves of cancer treatment using nanotechnology: 1) In the early 2000s, nanotechnology was applied to broad-spectrum chemotherapy agents. 2) After 2006, a second wave appeared using nanotechnology in chemotherapy agents and molecular targeted therapies for cancers like breast, lung, brain and colon. The paper also finds that since the late 2000s, research has intensified on treatments for cancers with high mortality rates like pancreatic and brain cancer. It shows countries specializing in specific cancers, such as Switzerland in prostate cancer and Japan in colon cancer. The ground-breaking trajectories of nanotechnology are generating revolutionary new treatments that
application of nanoparticles in the early diagnosis and treatment of tumors: ...LucyPi1
Abstract
Objective: Malignant tumors pose a serious threat to human life and health. Despite recent developments in
modern medical techniques, the early diagnosis and treatment of tumors remain difficult due to their asymptomatic
nature in the early stages of disease and the limitations in current clinical diagnostic methods. Advancements in
nanotechnology, particularly in the area of multi-functional diagnostic nanomaterials, can help effectively resolve
present inadequacies via concurrently achieving early diagnosis, image-guided intervention, and real-time
monitoring and treatment of tumors. The development of nanomaterials and nanotechnology may also aid in the
area of anti-cancer drug development by improving the safety and side-effect profile, as well as by enhancing the
targeted specificity of the drugs, which are two of the long-standing challenges in Western medicine. The progress
in the field of nanomaterials has also uncovered novel approaches for the clinical application of traditional Chinese
medicine because the combination of traditional Chinese medicine components with nanoparticles overcomes
various drawbacks, including poor water solubility, low bioavailability, and short half-life, of the former. Moreover,
nanoparticles also enhance the biological effectiveness and targeted specificity of these medicines. In this review,
we discuss the application of nanoparticles in the early diagnosis and treatment of tumors, through modern and
traditional medicine.
Scientific Research And Ethics by Manu ShreshthaManu Shreshtha
This document presents an overview of ethics with respect to science and research. It begins with definitions of ethics and discusses ethical theories like deontology, teleology, and utilitarianism. It then examines important historical events that shaped modern research ethics like the Nazi medical experiments and the Nuremberg Code. The document outlines principles for ethical research like informed consent and protecting vulnerable subjects. It discusses ethical concerns in qualitative and quantitative research and emphasizes the importance of ethics in protecting participants and ensuring research is conducted safely and for the benefit of all.
Novel biotechnologies : intervening in the brain Ilya Klabukov
This document from the Nuffield Council on Bioethics examines the ethical issues related to novel neurotechnologies that can intervene in the human brain. It discusses technologies like deep brain stimulation, transcranial magnetic stimulation, brain-computer interfaces, and neural stem cell therapies. The report analyzes the ethical considerations regarding how these technologies are developed, tested, regulated, and applied both for medical purposes and non-medical uses.
Thank You for referencing this work, if you find it useful!
Citation of a related scientific book:
Wac, K., Wulfovich, S. (2021). Quantifying Quality of Life, Series: Health Informatics, Springer Nature, Cham, Switzerland. The talk details:
Katarzyna Wac, “Remote quality of life assessment: ‘What is always speaking silently is the body'”. Digital Health Connect Conference, Sion, Switzerland
Video: https://www.digitalhealthconnect.ch/en/
introduction Bio ethics and preclinical and clinical trial by srota dawnSrota Dawn
Bioethics involves studying the ethical implications of biological discoveries and medical advances. It examines what decisions are morally right regarding issues in fields like genetics and drug research. Regulations like the Hippocratic Oath and more modern frameworks provide guidance. Preclinical research ethics evaluates a potential drug's effects through non-human animal tests before human trials. These aim to reduce animal use, refine methods, and replace animals when possible. Clinical trials in humans have phases to assess safety, efficacy, and long-term effects compared to existing treatments. Regulations like CPCSEA in India oversee animal welfare in research.
Human biosafety issues of nanomaterials used as nanomedicineAhmed Madni
1) The document discusses human biosafety issues related to the use of nanomaterials in nanomedicine. Some key issues are that nanoparticles have different physicochemical properties than bulk materials and can interact with biological molecules or accumulate in tissues after intravenous injection.
2) Many studies on nanomedicine focus on effectiveness but not safety evaluation. Nanoparticles may accumulate in organs and cause toxicity over time even if initially found biocompatible. Animal studies often use different testing methods than human clinical practice.
3) Other challenges include regulatory issues in approving nanomedicine, as well as potential environmental, social, and ethical concerns. Future areas of focus could include theranostic nanoparticles and organ-chip evaluation
Building the field of health policy and system research: social science mattersJorge Pacheco
The document discusses the challenges facing the field of Health Policy and Systems Research (HPSR), particularly the risk of "disciplinary capture" where a particular knowledge framework dominates. It argues this risk stems from clashes between positivist paradigms in clinical/biomedical research and relativist paradigms in social sciences. To develop HPSR, the field needs to recognize diverse disciplinary perspectives and engage across disciplines. Understanding health policies and systems demands multi- and inter-disciplinary inquiry.
T-MOBILE, the mobile phone giant, has been accused of “burying” a scientific report it commissioned that concluded handsets and masts contribute to cancer and genetic damage.
The report argued that officially recommended limits on radiation exposure should be cut to 1/1000th of those in force. The suggestion has not been taken up by the company or by regulators.
Campaigners claimed T-Mobile’s handling of the report was part of a wider pattern of behaviour by the industry in its efforts to keep discussion of the health risks off the agenda.
Challenges of Harnessing the Informatics Landscape to Promote Health Behavior...AmericanLegacyFoundation
The document discusses the challenges of using informatics and technology to promote public health and behavior change, noting that while tools now exist to accelerate scientific discovery and intervention delivery, traditional research methods have not adapted sufficiently. It argues for moving beyond single-level interventions and randomized controlled trials to approaches like just-in-time adaptive interventions and learning health systems integrated across multiple levels to achieve population impact.
Presentation given at Health Informatics and Knowledge Management conference
(http://publichealth.curtin.edu.au/HIKM/), as part of Australasian Computer Science Week 2012.
http://www.cs.rmit.edu.au/acsw2012/
This document discusses the importance of ethics in medical research. It begins by defining ethics and research, and identifies human subjects. It then reviews some unethical medical experiments from history, like the Tuskegee Syphilis Study, that lacked informed consent and caused harm. This led to various codes of ethics like the Nuremberg Code, Declaration of Helsinki, and Belmont Report to protect subjects. The three main principles of research ethics are respect for persons, beneficence, and justice. Special protections are needed for vulnerable groups. Overall, ethics aim to balance scientific advancement with subject welfare and rights.
Ethics are crucial in nursing research to protect participants and establish standards of care. Unethical studies in the past showed exploitation and harm. The Nuremberg Code and Belmont Report established principles of respect for persons, beneficence, and justice. Informed consent and IRB oversight now safeguard participants' rights and welfare.
Thank You for referencing this work, if you find it useful!
Citation of a related scientific book:
Wac, K., Wulfovich, S. (2021). Quantifying Quality of Life, Series: Health Informatics, Springer Nature, Cham, Switzerland.
The talk details:
Katarzyna Wac, “Multimodal Machine Learning for Quality of Life Assessment: Throwing Data at a Problem?”, Keynote at the ZHAW Digital Health Lab Day, September 2021, Winterthur, Switzerland
Video: https://www.zhaw.ch/de/forschung/departementsuebergreifende-kooperationen/digital-health-lab/3-digital-health-lab-day/
This document provides an introduction to medical ethics, including definitions, basic principles, and examples throughout history of unethical medical experiments that violated principles of ethics. It discusses key concepts like beneficence, respect for human dignity, autonomy, justice and informed consent. It summarizes notorious cases of unethical human experimentation like the Lübeck disaster, Dr. J. Marion Sims' experiments on slave women, Nazi human experiments during World War II, and guidelines developed in response like the Nuremberg Code and Declaration of Helsinki to protect human subjects in research.
Thank You for referencing this work, if you find it useful!
Citation of a related scientific paper:
Berrocal, A., Manea, V., De Masi, A., Wac, K. mQoL-Lab: Step-by-Step Creation of a Flexible Platform to Conduct Studies Using Interactive, Mobile, Wearable and Ubiquitous Devices, MobiSPC 2020
The talk details:
Alexandre De Masi, Igor Matias, Vlad Manea, Allan Berrocal, Katarzyna Wac, “mQoL: Methodology for Assessing and Modeling Human Aspects in Interactive, Mobile, Wearable and Ubiquitous Computing in Situ”, International Transdisciplinarity Conference (ITD) 2021, September 2021.
Video: https://youtu.be/dIxOnqd5g8E
The document provides an overview of the history of research ethics and key events that led to the establishment of ethical guidelines and regulations. It discusses scandals such as the Tuskegee Syphilis Study and experiments conducted by Nazi Germany. These events prompted milestones like the Nuremberg Code, Declaration of Helsinki, and Belmont Report. The Belmont Report outlines basic ethical principles including respect for persons, beneficence, and justice that provide a framework for resolving issues in human subjects research.
Bioethics including ethics in collaborative research and publication ethicsArati Mishra Ingalageri
The document discusses research ethics and publication ethics. It provides an overview of the history and development of research ethics beginning with the Nuremberg Code created after World War 2 in response to unethical human experimentation. It discusses guidelines like the Declaration of Helsinki and Belmont Report that further developed ethical standards. Key aspects of research ethics discussed include informed consent, treatment of human/animal subjects, and codes of conduct. The document also outlines publication ethics standards regarding authorship, plagiarism, peer review, and data sharing.
The document discusses several key topics related to research ethics including definitions of ethics, important ethical principles like beneficence, respect for human dignity and justice, historical events that shaped modern research ethics like the Nazi experiments and Tuskegee study, informed consent, vulnerable populations, and codes of ethics. It also addresses ethical issues in different research methodologies and the role of institutional review boards in research oversight.
Drug Efficacy, Safety, and Biologics Discovery:Sean Ekins
This book provides an overview of emerging technologies for drug efficacy, safety, and biologics discovery. It is divided into three parts that discuss drug efficacy and safety technologies, biologics technologies, and future perspectives. The 14 chapters cover topics such as systems pharmacology, biomarkers, zebrafish models, toxicity pathways, stem cells, nanotechnology, and biological engineering. The book advocates an interdisciplinary approach and applying the four modalities of manipulate, measure, mine, and model to drug research. It presents technological advances that can improve predictions of drug properties and foster collaboration across small and large molecule discovery.
Nanotechnology involves manipulating matter at the atomic and molecular scale, typically 100 nanometers or smaller. Richard Feynman first suggested the possibility of nanomachines in 1959. Albert Hibbs later suggested using nanomachines for medical purposes like surgery. Current applications of nanotechnology in medicine include targeted drug delivery, cancer treatment using gold nanoparticles, microsurgery using nanoscale instruments, medical robotics, and tissue engineering. While nanomedicine holds promise, it also raises social, economic, ethical, and safety issues that warrant careful consideration and oversight to ensure its safe and equitable development and use.
Nanotechnology involves controlling and manipulating matter at the atomic and molecular scale, typically 100 nanometers or smaller. Richard Feynman first suggested the possibility of nanomachines in 1959. Albert Hibbs later suggested using nanomachines for medical purposes like surgery. Today, nanotechnology has many medical applications including more targeted drug delivery, cancer treatment using gold nanoparticles, microsurgery using nanoscale instruments, medical robotics, and tissue engineering. While nanomedicine holds promise, it also raises social, economic, ethical and safety issues that must be addressed through careful development and regulation.
Nanotechnology involves manipulating matter at the atomic or molecular scale, typically 100 nanometers or smaller. Richard Feynman first suggested the possibility of nanomachines in 1959. Albert Hibbs later suggested using nanomachines for medical purposes like surgery. Current applications of nanotechnology in medicine include more targeted drug delivery, cancer treatment using gold nanoparticles, microsurgery using nanoscale instruments, medical robotics, and tissue engineering. While nanomedicine holds promise, it also raises social, economic, ethical, and safety issues that warrant careful consideration and oversight to ensure its safe and equitable development and use.
This document discusses the ethics of nanotechnology. It notes that while nanotechnology provides benefits, there are also risks that need to be addressed. Specifically, it points out that less than $500,000 was spent studying the environmental effects of nanotechnology despite $700 million in funding. It also says that guidelines need to be established to prevent unethical uses of nanotechnology by free-lance or government researchers.
This document provides an overview of the application of nanotechnology in biomedicine. It discusses how nanoparticles can be used for diagnostic and therapeutic purposes, including for cancer detection and drug delivery. The document describes several types of nanoparticles that are being researched, such as liposomes, polymeric nanoparticles, metallic nanoparticles, and metal oxide nanoparticles. It also discusses some of the methods used to produce nanoparticles and highlights potential safety issues that require further study before clinical use.
Mathieu Noury_From nanomedicine to nanohealth conceptualizing the biomedical ...Ne3LS_Network
1. Nanomedicine aims to comprehensively monitor, repair, and improve human biological systems at the molecular level using engineered nanostructures to achieve medical benefits. Nanohealth analyzes the social and cultural implications of the biomedical model proposed by nanomedicine.
2. Nanohealth proposes a transversal medical model involving predictive, personalized, and regenerative medicine enabled by nanotechnology.
3. Nanomedicine represents an enhancement medicine that optimizes human bodies and promotes health and disease prevention beyond curing illness.
4. Major governments are investing heavily in nanotechnology, including nanomedicine, creating a global race to develop these technologies and harness their economic
This document provides an overview of nanomedicine and outlines several key areas. It begins by defining nanomedicine and its applications in areas like diagnostics, therapeutics, and future technologies. The introduction then summarizes some of the major achievements in the field over the past 15 years. The remainder of the document contains 8 articles that discuss topics like the design of nanomedicines, their interactions with the immune system, applications for diseases like cancer, diabetes, stroke and atherosclerosis, and the importance of patient stratification. It highlights how controlling properties like size, shape, surface characteristics and mechanics can improve drug delivery and addresses challenges to further clinical translation of nanomedicines.
Human biosafety issues of nanomaterials used as nanomedicineAhmed Madni
1) The document discusses human biosafety issues related to the use of nanomaterials in nanomedicine. Some key issues are that nanoparticles have different physicochemical properties than bulk materials and can interact with biological molecules or accumulate in tissues after intravenous injection.
2) Many studies on nanomedicine focus on effectiveness but not safety evaluation. Nanoparticles may accumulate in organs and cause toxicity over time even if initially found biocompatible. Animal studies often use different testing methods than human clinical practice.
3) Other challenges include regulatory issues in approving nanomedicine, as well as potential environmental, social, and ethical concerns. Future areas of focus could include theranostic nanoparticles and organ-chip evaluation
Building the field of health policy and system research: social science mattersJorge Pacheco
The document discusses the challenges facing the field of Health Policy and Systems Research (HPSR), particularly the risk of "disciplinary capture" where a particular knowledge framework dominates. It argues this risk stems from clashes between positivist paradigms in clinical/biomedical research and relativist paradigms in social sciences. To develop HPSR, the field needs to recognize diverse disciplinary perspectives and engage across disciplines. Understanding health policies and systems demands multi- and inter-disciplinary inquiry.
T-MOBILE, the mobile phone giant, has been accused of “burying” a scientific report it commissioned that concluded handsets and masts contribute to cancer and genetic damage.
The report argued that officially recommended limits on radiation exposure should be cut to 1/1000th of those in force. The suggestion has not been taken up by the company or by regulators.
Campaigners claimed T-Mobile’s handling of the report was part of a wider pattern of behaviour by the industry in its efforts to keep discussion of the health risks off the agenda.
Challenges of Harnessing the Informatics Landscape to Promote Health Behavior...AmericanLegacyFoundation
The document discusses the challenges of using informatics and technology to promote public health and behavior change, noting that while tools now exist to accelerate scientific discovery and intervention delivery, traditional research methods have not adapted sufficiently. It argues for moving beyond single-level interventions and randomized controlled trials to approaches like just-in-time adaptive interventions and learning health systems integrated across multiple levels to achieve population impact.
Presentation given at Health Informatics and Knowledge Management conference
(http://publichealth.curtin.edu.au/HIKM/), as part of Australasian Computer Science Week 2012.
http://www.cs.rmit.edu.au/acsw2012/
This document discusses the importance of ethics in medical research. It begins by defining ethics and research, and identifies human subjects. It then reviews some unethical medical experiments from history, like the Tuskegee Syphilis Study, that lacked informed consent and caused harm. This led to various codes of ethics like the Nuremberg Code, Declaration of Helsinki, and Belmont Report to protect subjects. The three main principles of research ethics are respect for persons, beneficence, and justice. Special protections are needed for vulnerable groups. Overall, ethics aim to balance scientific advancement with subject welfare and rights.
Ethics are crucial in nursing research to protect participants and establish standards of care. Unethical studies in the past showed exploitation and harm. The Nuremberg Code and Belmont Report established principles of respect for persons, beneficence, and justice. Informed consent and IRB oversight now safeguard participants' rights and welfare.
Thank You for referencing this work, if you find it useful!
Citation of a related scientific book:
Wac, K., Wulfovich, S. (2021). Quantifying Quality of Life, Series: Health Informatics, Springer Nature, Cham, Switzerland.
The talk details:
Katarzyna Wac, “Multimodal Machine Learning for Quality of Life Assessment: Throwing Data at a Problem?”, Keynote at the ZHAW Digital Health Lab Day, September 2021, Winterthur, Switzerland
Video: https://www.zhaw.ch/de/forschung/departementsuebergreifende-kooperationen/digital-health-lab/3-digital-health-lab-day/
This document provides an introduction to medical ethics, including definitions, basic principles, and examples throughout history of unethical medical experiments that violated principles of ethics. It discusses key concepts like beneficence, respect for human dignity, autonomy, justice and informed consent. It summarizes notorious cases of unethical human experimentation like the Lübeck disaster, Dr. J. Marion Sims' experiments on slave women, Nazi human experiments during World War II, and guidelines developed in response like the Nuremberg Code and Declaration of Helsinki to protect human subjects in research.
Thank You for referencing this work, if you find it useful!
Citation of a related scientific paper:
Berrocal, A., Manea, V., De Masi, A., Wac, K. mQoL-Lab: Step-by-Step Creation of a Flexible Platform to Conduct Studies Using Interactive, Mobile, Wearable and Ubiquitous Devices, MobiSPC 2020
The talk details:
Alexandre De Masi, Igor Matias, Vlad Manea, Allan Berrocal, Katarzyna Wac, “mQoL: Methodology for Assessing and Modeling Human Aspects in Interactive, Mobile, Wearable and Ubiquitous Computing in Situ”, International Transdisciplinarity Conference (ITD) 2021, September 2021.
Video: https://youtu.be/dIxOnqd5g8E
The document provides an overview of the history of research ethics and key events that led to the establishment of ethical guidelines and regulations. It discusses scandals such as the Tuskegee Syphilis Study and experiments conducted by Nazi Germany. These events prompted milestones like the Nuremberg Code, Declaration of Helsinki, and Belmont Report. The Belmont Report outlines basic ethical principles including respect for persons, beneficence, and justice that provide a framework for resolving issues in human subjects research.
Bioethics including ethics in collaborative research and publication ethicsArati Mishra Ingalageri
The document discusses research ethics and publication ethics. It provides an overview of the history and development of research ethics beginning with the Nuremberg Code created after World War 2 in response to unethical human experimentation. It discusses guidelines like the Declaration of Helsinki and Belmont Report that further developed ethical standards. Key aspects of research ethics discussed include informed consent, treatment of human/animal subjects, and codes of conduct. The document also outlines publication ethics standards regarding authorship, plagiarism, peer review, and data sharing.
The document discusses several key topics related to research ethics including definitions of ethics, important ethical principles like beneficence, respect for human dignity and justice, historical events that shaped modern research ethics like the Nazi experiments and Tuskegee study, informed consent, vulnerable populations, and codes of ethics. It also addresses ethical issues in different research methodologies and the role of institutional review boards in research oversight.
Drug Efficacy, Safety, and Biologics Discovery:Sean Ekins
This book provides an overview of emerging technologies for drug efficacy, safety, and biologics discovery. It is divided into three parts that discuss drug efficacy and safety technologies, biologics technologies, and future perspectives. The 14 chapters cover topics such as systems pharmacology, biomarkers, zebrafish models, toxicity pathways, stem cells, nanotechnology, and biological engineering. The book advocates an interdisciplinary approach and applying the four modalities of manipulate, measure, mine, and model to drug research. It presents technological advances that can improve predictions of drug properties and foster collaboration across small and large molecule discovery.
Nanotechnology involves manipulating matter at the atomic and molecular scale, typically 100 nanometers or smaller. Richard Feynman first suggested the possibility of nanomachines in 1959. Albert Hibbs later suggested using nanomachines for medical purposes like surgery. Current applications of nanotechnology in medicine include targeted drug delivery, cancer treatment using gold nanoparticles, microsurgery using nanoscale instruments, medical robotics, and tissue engineering. While nanomedicine holds promise, it also raises social, economic, ethical, and safety issues that warrant careful consideration and oversight to ensure its safe and equitable development and use.
Nanotechnology involves controlling and manipulating matter at the atomic and molecular scale, typically 100 nanometers or smaller. Richard Feynman first suggested the possibility of nanomachines in 1959. Albert Hibbs later suggested using nanomachines for medical purposes like surgery. Today, nanotechnology has many medical applications including more targeted drug delivery, cancer treatment using gold nanoparticles, microsurgery using nanoscale instruments, medical robotics, and tissue engineering. While nanomedicine holds promise, it also raises social, economic, ethical and safety issues that must be addressed through careful development and regulation.
Nanotechnology involves manipulating matter at the atomic or molecular scale, typically 100 nanometers or smaller. Richard Feynman first suggested the possibility of nanomachines in 1959. Albert Hibbs later suggested using nanomachines for medical purposes like surgery. Current applications of nanotechnology in medicine include more targeted drug delivery, cancer treatment using gold nanoparticles, microsurgery using nanoscale instruments, medical robotics, and tissue engineering. While nanomedicine holds promise, it also raises social, economic, ethical, and safety issues that warrant careful consideration and oversight to ensure its safe and equitable development and use.
This document discusses the ethics of nanotechnology. It notes that while nanotechnology provides benefits, there are also risks that need to be addressed. Specifically, it points out that less than $500,000 was spent studying the environmental effects of nanotechnology despite $700 million in funding. It also says that guidelines need to be established to prevent unethical uses of nanotechnology by free-lance or government researchers.
This document provides an overview of the application of nanotechnology in biomedicine. It discusses how nanoparticles can be used for diagnostic and therapeutic purposes, including for cancer detection and drug delivery. The document describes several types of nanoparticles that are being researched, such as liposomes, polymeric nanoparticles, metallic nanoparticles, and metal oxide nanoparticles. It also discusses some of the methods used to produce nanoparticles and highlights potential safety issues that require further study before clinical use.
Mathieu Noury_From nanomedicine to nanohealth conceptualizing the biomedical ...Ne3LS_Network
1. Nanomedicine aims to comprehensively monitor, repair, and improve human biological systems at the molecular level using engineered nanostructures to achieve medical benefits. Nanohealth analyzes the social and cultural implications of the biomedical model proposed by nanomedicine.
2. Nanohealth proposes a transversal medical model involving predictive, personalized, and regenerative medicine enabled by nanotechnology.
3. Nanomedicine represents an enhancement medicine that optimizes human bodies and promotes health and disease prevention beyond curing illness.
4. Major governments are investing heavily in nanotechnology, including nanomedicine, creating a global race to develop these technologies and harness their economic
This document provides an overview of nanomedicine and outlines several key areas. It begins by defining nanomedicine and its applications in areas like diagnostics, therapeutics, and future technologies. The introduction then summarizes some of the major achievements in the field over the past 15 years. The remainder of the document contains 8 articles that discuss topics like the design of nanomedicines, their interactions with the immune system, applications for diseases like cancer, diabetes, stroke and atherosclerosis, and the importance of patient stratification. It highlights how controlling properties like size, shape, surface characteristics and mechanics can improve drug delivery and addresses challenges to further clinical translation of nanomedicines.
Ethical considerations in molecular & biotechnology researchDr Ghaiath Hussein
A lecture presented by Dr. Ghaiath Hussein in University of Khartoum for the students of the MSc programme in Genetics/Molecular Biology.
Session 1 (Introduction): Definition of ethics, bioethics and medical ethics.
What is an ethical issue?
International approaches to medical ethics
Islamic approaches to medical ethics
Nano-Biomaterials and Their Biocompatibility in Restorative Dentistry: A Reviewinventionjournals
Human healthcare is facing a major uprising in the wake of ongoing technological expansions in the field of nanotechnology. Incorporation of nanotechnology into dentistry will make possible the maintenance of near perfect oral environment by using nanomaterials, including tissue engineering, and ultimately, dental nanorobots. New potential treatment prospects in dentistry may include: dentition renaturalization and permanent hypersensitivity cure, local anaesthesia, complete orthodontic realignments during a single office visit, covalently bonded diamondised enamel, and oral health maintenance using mechanical dentifrobots, to destroy bacteria in the mouth that cause dental caries or even repair spots on the teeth where decay has set in, by use of computer to direct these tiny workers in their tasks. Nanodentistry still faces many significant challenges in realizing its tremendous potential. There are larger social issues of public acceptance, regulations, ethics and human safety that must be taken into consideration before molecular nano-technology can enter the modern medical armamentarium. However, there is equally powerful motivation to surmount these various challenges such as the possibility of providing high quality dental care to 80% of the population that at present receives no noteworthy dental care. Time, financial and scientific resources, specific advances and human needs will conclude which of the applications to be realized first!
This document discusses the history and principles of healthcare ethics. It outlines key events that led to the establishment of international ethical standards for research involving human subjects, such as the Nuremberg Code and Declaration of Helsinki. The four main principles of healthcare ethics are also presented: autonomy, beneficence, non-maleficence, and justice. A case study example shows how a doctor must consider all these principles when making decisions about a patient's treatment.
The workshop aimed to promote the development and use of atomically precise tools for medical applications. About 50 researchers from diverse fields attended to identify potential collaborations and near-term research projects. The workshop developed several example projects, such as using artificial immune systems or DNA robots to treat diseases. It also identified how precise tools could repair DNA, stem cells, or control blood composition to treat medical issues.
This document provides an overview of nanomedicine and its potential applications. It discusses how nanotechnology can be applied to improve drug delivery through targeted delivery at the subcellular level. Some key applications mentioned include using nanoparticles for drug and gene delivery, as well as for molecular imaging and diagnostics. The document also notes the vast economic potential of nanotechnology and its anticipated $1 trillion impact over the next 15-20 years.
The document summarizes key topics related to nanosafety in a nanomaterials and nanotechnology course taught by Dr. XA Sun. It discusses potential hazards of nanomaterials, important considerations for nanosafety including proper personal protective equipment, engineering controls, and safe handling practices. It also notes challenges in characterizing nanomaterials and a lack of standards and regulations. The document emphasizes the need for more research on nanosafety and collaboration between researchers and environmental health and safety experts to develop effective safety protocols and practices.
Nanotechnology for cancer therapy recent developmentsroshan telrandhe
1. The document discusses recent developments in using nanotechnology for cancer therapy. It describes how nanoparticles can be used to target delivery of drugs specifically to tumor cells, reducing side effects on healthy cells.
2. Various nanotechnology platforms for drug delivery are reviewed, including polymeric nanoparticles, liposomes, dendrimers, and nucleic acid-based nanoparticles. The targeted delivery allows for higher drug doses to be used against cancer cells.
3. The review discusses both preventative and treatment applications of nanotechnology. Preventatively, nanoparticles could deliver sunscreen agents directly to skin cells. In treatment, nanoparticles are being used to more effectively deliver drugs like paclitaxel for prostate cancer therapy.
The document discusses the need for regulations governing nanomedicine to balance innovation with safety. It notes that while nanotechnology could revolutionize medicine through targeted drug delivery, imaging, and implantable devices, uncertainty around the approval process may slow development. For regulations to be effective, they must consider nanoparticles' unique interactions with biology and potential long-term effects, requiring careful pre-clinical testing and expert review. Standards for characterization, testing, and oversight bodies will help minimize risks as nanomedicine moves from pre-clinical research to applications that improve human health.
The document discusses the need for regulations to govern nanomedicine as it holds promise but also risks. It notes that while nanoparticles show potential in drug delivery, imaging and implants, regulatory frameworks have not fully addressed their oversight. It advocates that meticulous pre-clinical testing and expert review can help minimize risks until standards, definitions and safety protocols are in place to properly assess nanomaterials' interactions and impacts in biological systems.
Designing of drug delivery system for biotechnology products considering stab...Smaranika Rahman
This document discusses drug delivery systems for biotechnology products, focusing on stability aspects and monitoring methods to improve stability. It provides background on biotechnology and its history, then describes various routes for delivering biotech products, including orally, nasally, transdermally, parenterally, and rectally. For each route, it discusses technologies being investigated or developed to enhance stability and absorption of biotech drugs, such as using polymers, absorption enhancers, and targeted delivery methods. The goal is to develop delivery systems that can safely and reliably deliver biotech medications at therapeutic levels.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
1. WHY ETHICAL SAFEGUARDS MATTER IN MEDICAL NANOTECHNOLOGY:
PROSPECTS AND PROBLEMS IN THE DELIVERY OF NANOMEDICINE VIA
MICROSURGICAL INTERVENTIONS
Tista Bagchi
University of Delhi
Delhi – 110007, India
2. 1.Introduction: Why ethical safeguards?
Excerpt from the Hippocratic oath:
“I will follow that system of regimen which, according to my ability and
judgement, I consider for the benefit of my patients, and abstain from
whatever is deleterious and mischievous.” (Translation quoted from
Britannica Online; cf. also Craik 2015)
Between
The Nuremberg Code on experiments involving human subjects, 1947, post-
war, and
The Helsinki Declaration on experimental research on human subjects, 1964
-- India was at the vanguard of formulating a code of medical ethics (covering
not just experimental research but medical interventions involving human
patients overall), through the Medical Council of India, made public in 1956.
3. 2. Method(s) to arrive at ethical safeguards
for new medical science & technologies
Absolute moral rules, such as proposed by the late ethicist / bioethicist Bernard
Gert (1998) – of which the following six might be of interest in our context:
- “Do not kill”
- “Do not cause pain”
- “Do not disable”
- “Do not deprive of freedom”
- “Do not deceive”
- “Be fair”
Gert, however, acknowledges that these may have to be violated under certain
circumstances; see also Gert, Culver, and Clouser (2006) for a more direct
discussion of issues relating to medical ethics.
4. 2.1 Reflective Equilibrium
This work can be shown to derive to a large extent (admittedly with some major
qualifications) from a more comprehensive approach to issues relating to justice
laid out by the late legal and social philosopher John Rawls (1971 / 1999),
The Method of Reflective Equilibrium
(the term was initially applied to the principles of logical reasoning by the
philosopher Nelson Goodman; Rawls then applied and popularized it as a
method in the domains of ethics and the law)
-- “the end-point of a deliberative process in which we reflect on and revise
our beliefs about an area of inquiry, moral or non-moral” and
-- it “consists in working back and forth among our considered judgments” …
“about particular instances or cases, the principles or rules that we believe
govern them, and the theoretical considerations that we believe bear on a
ccepting these considered judgments, principles, or rules, revising any of these
elements wherever necessary in order to achieve an acceptable coherence among
them”(Daniels 2003/2016).
5. 2.2 Applications of the method to
medicine and medical technology
For regulatory policy and (ethical) safeguards:
For deliberation on particular cases:
-- Problem: Not all medical professionals who are or might be handling
nanomedicine or related technologies necessarily have “considered moral
judgements”
-- Herein lies the value of well-formulated regulatory policy and (ethical)
safeguards that can (at least partially) show the way
For future safeguards, e.g., against irresponsible use & use in bio-terror
6. 3. Microsurgical interventions and
delivery of nanomedicine -- issues
The order of magnitude of microsurgery is very different from …
that of medical nanotechnology:
7. 3.1 Procedural issues
Combining (i) drug delivery via nanotechnology with (ii) microsurgical procedures
such as fine incisions or laparoscopic microsurgery looks promising for a variety of
medical problems, from malignant tumors to cardiovascular blockages to even
fertility and assisted reproductive treatments.
Nanosurgery itself, of course, has long since been attempted using (a) atomic
force microscopy with a nanoneedle, and (b) femtosecond laser surgery (as
reported by Ebbesen & Jensen 2006); however, in this instance there is still
considerable expense involved, as compared to the relative economy in employing
microsurgery and nanomedical drug-delivery technology in combination, especially
in a variety of medical-institutional situations globally. Also, given that
nanosurgery is conducted at the level of the “really tiny”, its scaleability for really
meaningful surgical intervention is still in doubt.
For the two levels of magnitude, an analogy is to be found from different levels of
organization found in (spoken) language –
the phonetic level of speech-sounds (with their distinctive articulatory and
acoustic features) and the morphological level of the building blocks of words
8. Procedural issues (contd.)
Microsurgical intervention
e.g., in neurosurgery:
Polymeric micelles for drug(or neurotransmitter) delivery – as other
presentations here should amply illustrate, there are multiple carrier types:
9. 3.2 Ethical issues – prudential versus
moral ones
Besides what is morally right or wrong to do, ethical deliberation also
encompasses what is prudentially correct to pursue – i.e., is likely to lead to
desirable consequences in practical terms (a distinction made by Immanuel
Kant, 1785/2002).
A “precautionary principle” has been proposed – however, “the principle can
be scientific provided that (1) the threats addressed by the principle are
plausible threats, and (2) the precautionary measures adopted are
reasonable.” (Resnik 2003: 329)
More generally: “As the science and technology of nanomedicine speed
ahead, ethics, policy and the law are struggling to keep up. It is important to
proactively address the ethical, social and regulatory aspects of nanomedicine
in order to minimize its adverse impacts on the environment and public
health and also to avoid a public backlash.” (Resnik & Tinkle 2007: 345)
10. 4.Existing safeguards
Mostly blanket safeguards for research and practice in medicine and medical
nanotechnology in most parts of the world thus far
However, some of the best guidelines for nanomedicine are those put out by
the European Medicines Agency (“EuroMed”) – including
-- development of block-copolymer-micelle medicinal products
-- Guidance on the Determination of Potential Health Effects of Nanomaterials
Used in Medical Devices
-- committees to oversee specific domains, e.g.
• Committee for Medicinal Products for Human Use
• Pharmacovigilance Risk Assessment Committee
• Committee for Advanced Therapies
• Pediatric Committee
In India, there are beginnings in the governance of nanomedicine and medical
nanotechnology under the overall guidelines of the Indian Council for Medical
Research (ICMR) and also the Department of Science & Technology (DST) – Bhatia &
Chugh (2016);
-- ethical concerns are also expressed in the final chapter of Sundar Rajan (2016).
11. 5. To conclude
A point to emphasize in conclusion:
Ethical safeguards are not meant to unduly or unfairly constrain treatment
and/or research in nanomedicine but are in fact meant to help patients
and professionals/researchers navigate their way through the complex
routes of new medical protocols and technologies.
While there are of course safeguards that apply to microsurgery, and –
increasingly – safeguards dedicated to nanomedicine in various parts of the
world, the time has come to seriously consider and work out in detail ethical
safeguards that are dedicated to the interface between the two.
This is with a view toward positive growth of further applications and
developments in the combination of the two for better and better treatment
options in nanomedicine and medical nanotechnological methods with a view
toward benefitting people worldwide.
13. References
Bagchi, Tista. 2015. Between life-creation and policy formulation. In Science,
Technology, and Development in India: Encountering Values, ed. Rajeswari S. Raina,
188-203. New Delhi: Orient BlackSwan.
Benatar, Solomon, and Peter A. Singer. 2010. Responsibilities in international research:
A new look revisited. Editorial, Journal of Medical Ethics 36: 194-197.
Bhatia, Pooja, and Archana Chugh. 2016. A multilevel governance framework for
regulation of nanomedicine in India. Nanotechnology Reviews, doi:10.1515/ntrev-2016-
0083 (retrieved 7/16/2017)
Buchanan, Allen, Dan W. Brock, Norman Daniels, and Daniel Wikler. 2001. From
Chance to Choice: Genetics and Justice. Cambridge: Cambridge University Press.
Craik, Elizabeth M., ed. 2015. The ‘Hippocratic’ Corpus: Content and Context.
London: Routledge.
Daniels, Norman. 2003, revised 2016. Reflective equilibrium. Stanford Encyclopedia
of Philosophy (Winter 2016 edition), ed. Edward N. Zalta, URL
https://plato.stanford.edu/archives/win2016/entries/reflective-equilibrium/
(retrieved 7/14/2017)
Ebbesen, Mette, and Thomas G. Jensen. 2006. Nanomedicine: Techniques, potentials,
and ethical implications. Journal of Biomedicine and Biotechnology 2006: 1-11. DOI
10.1155/JBB/2006/51516
14. References (contd.)
Gert, Bernard. 1998. Morality: Its Nature and Justification. New York: Oxford
University Press.
Gert, Bernard, Charles M. Culver, and K. Danner Clouser. 2006. Bioethics: A
Systematic Approach. New York: Oxford University Press.
Kant, Immanuel Kant. 1785 / 2002. Groundwork for the Metaphysics of Morals.
Translated by Allen W. Wood, with essays by J. B. Schneewind, Marcia Baron,
Shelly Kagan, and Allen W. Wood. New Haven & London: Yale University Press.
Rawls, John. 1971, revised edition 1999. A Theory of Justice. Oxford: Clarendon
Press / Oxford University Press.
Resnik, David B. 2003. Is the precautionary principle unscientific? Studies in
History and Philosophy of Science, Part C: Studies in History and Philosophy of
Biological and Biomedical Sciences 34(2): 329-344.
https://doi.org/10.1016/S1369-8486(02)00074-2 (retrieved 7/10/2017)
Resnik, David B., and S. S. Tinkle. 2007. Ethics in nanomedicine. Nanomedicine
(Lond.) 2(3): 345-350. https://www.ncbi.nlm.nih.gov/pubmed/17716179
(retrieved 5/15/2017).
Sundara Rajan, Mohan. 2016. Nano: The Next Revolution, 3rd edition. New Delhi:
National Book Trust.